Abstract
Mouse or rat brain cortex slices were preincubated with 3H-noradrenaline and superfused with physiological salt solution containing desipramine. We studied the effects of prostaglandin E2 (PGE2), prostaglandin D2 (PGD2) and related drugs on the electrically evoked (50 mA, 2 ms, 0.3 Hz) tritium overflow.
PGE2 inhibited the electrically evoked tritium overflow from mouse brain cortex slices; the maximum effect of PGE2 (79010) was attenuated by the α2-adrenoceptor agonist talipexole (to 52010) and enhanced by the α2-adrenoceptor antagonist rauwolscine (to 92%). Rauwolscine was added to the superfusion medium in all subsequent experiments. The effect of PGE2 was readily reversible upon withdrawal from the medium and remained constant upon prolonged exposure of the tissue to the prostanoid. Studies with EP receptor agonists, mimicking the inhibitory effect of PGE2, showed the following potencies (pIC50): sulprostone (8.22); misoprostol (8.00); PGE2 (7.74); PGEZ (7.61); iloprost (5.86). The concentration-response curve of PGE2 was marginally shifted to the right by the EP1 receptor antagonist AH 6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid; apparent pA2 3.97) and by the TP receptor antagonist vapiprost (4.50). AH 6809, by itself, did not affect the evoked overflow whereas vapiprost increased it. PGD2 inhibited the evoked overflow at high concentrations (pIC50 4.90); this effect was not altered by the DP receptor antagonist BW A868C (3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2hydroxyethylamino)hydantoin), which, by itself, did not affect the evoked overflow. Indometacin slightly increased the evoked overflow and tended to increase the inhibitory effect of PGE2. PGE2 inhibited the electrically evoked tritium overflow also in rat brain cortex slices. The maximum effect (obtained in the presence of rauwolscine) was 61%; the pIC30 value was 7.67.
The present study suggests that PGE2 inhibits noradrenaline release from mouse brain cortex via EP3 receptors and that its maximum effect is more marked in the mouse than in the rat. The inhibitory effect of PGD2 (in the mouse brain) does not involve DP receptors and may also be related to EP3 receptors. The EP3 receptors interact with a2-adrenoceptors and may be activated by endogenous prostanoids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adam M, Boie Y, Rushmore TH, Müller G, Bastien L, McKee KT, Metters KM, Abramowitz M (1994) Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett 338:170–174
Ahluwalia A, Head SA, Sheldrick RLG, Coleman RA (1988) Prostanoid receptors mediating contraction of rabbit renal artery. Br J Pharmacol 95:721P
Allgaier C, Jäger T, Hertting G (1989) Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release. Naunyn-Schmiedeberg's Arch Pharmacol 340:472–474
Bognar IT, Albrecht SA, Farasaty M, Schmitt E, Seidel G, Fuder H (1994) Effects of human recombinant interleukins on stimulation-evoked noradrenaline overflow from the rat perfused spleen. Naunyn-Schmiedeberg's Arch Pharmacol 349:497–502
Coleman RA, Smith WL, Narumiya S (1994a) International Union of Pharmacology. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205–229
Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A, Sheldrick RLG (1994b) A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47:151–168
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology, vol XXXIII. Springer, Berlin Heidelberg New York, pp 283–335
Hedqvist P (1974) Prostaglandin action on noradrenaline release and mechanical responses in the stimulated guinea-pig vas deferens. Acta Physiol Scand 90:86–93
Hedqvist P (1977) Basic mechanisms of prostaglandin action on autonomic neurotransmission. Annu Rev Pharmacol Toxicol 17:259–279
Jones RL, Wilson NH (1990) An EP3-receptor may mediate prostaglandin E-induced potentiation of aggregation in human platelets. Br J Pharmacol 101:522P
Malik KU, Sehic E (1990) Prostaglandins and the release of the adrenergic transmitter. Ann NY Acad Sci 604:222–236
Malinowska B, Exner HJ, Godlewski G, Buczko W, Schlicker E (1994a) EP3 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat and of noradrenaline release in the mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 349 [Suppl]:R78
Malinowska B, Godlewski G, Buczko W, Schlicker E (1994b) EP3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur J Pharmacol 259:315–319
Mayer ML, Vyklicky L, Benveniste M, Patneau D, Williamson L (1991) Desensitization at NMDA and AMPA kainate receptors. In: Wheal H, Thomson A (eds) Excitatory amino acids and synaptic transmission. Academic Press, London, pp 123–140
Molderings GJ, Göthert M (1990) Mutual interaction between presynaptic α2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava. Naunyn-Schmiedeberg's Arch Pharmacol 341:391–397
Molderings GJ, van Ahlen H, Göthert M (1992a) Modulation of noradrenaline release in human corpus cavernosum by presynaptic prostaglandin receptors. Int J Impotence Res 4:19–25
Molderings G, Malinowska B, Schlicker E (1992b) Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. Br J Pharmacol 107:352–355
Molderings GJ, Colling E, Likungu J, Jakschik J, Göthert M (1994) Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors. Br J Pharmacol 111: 733–738
Nakajima M, Toda N (1984) Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries. Prostaglandins 27:407–419
Namima M, Okamoto K (1987) Modulatory action of prostaglandin D2 on the release of 3H-norepinephrine from rat cerebellar slices. Jpn J Pharmacol 43:197–204
Ohia SE, Jumblatt JE (1990) Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit irisciliary body. J Pharmacol Exp Ther 255:11–16
Racké K, Bähring J, Langer C, Bräutigam M, Wessler I (1992) Prostanoids inhibit release of endogenous norepinephrine from rat isolated trachea. Am Rev Respir Dis 146:1182–1186
Reimann W, Steinhauer HB, Hedler L, Starke K, Hertting G (1981) Effects of prostaglandins D2, E2 and F2α on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol 69:421–427
Schaad NC, Magistretti PJ, Schorderet M (1991) Prostanoids and their role in cell-cell interactions in the central nervous system. Neurochem Int 18:303–322
Schlicker E, Behling A, Lümmen G, Malinowska B, Göthert M (1992a) Mutual interaction of histamine H3-receptors and α2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 345:639–646
Schlicker E, Behling A, Lummen G, Göthert M (1992b) Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 345:489–493
Schlicker E, Lummen G, Behling A, Gothert M (1992c) Inhibition of noradrenaline release via NEM-sensitive H3 receptors in the mouse brain cortex: more marked effect than in the rat brain. Agents Actions (Special Conference Issue):C339–C342
Schlicker E, Kathmann M, Detzner M, Exner HJ, Göthert M (1994) H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+' and K+ ions, G protein and adenylate cyclase. Naunyn-Schmiedeberg's Arch Pharmacol 350:34–41
Sheldrick RLG, Coleman RA, Lumley P (1988) Iloprost — a potent EP1- and IP-receptor agonist. Br J Pharmacol 94:334P
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124
Wolfe LS (1982) Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 38:1–14
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Exner, H.J., Schlicker, E. Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 351, 46–52 (1995). https://doi.org/10.1007/BF00169063
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169063